ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

OSCR vs CAI // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

Oscar Health Inc. (NYSE) VS. Caris Life Sciences Inc. (NASDAQ) • 15-METRIC TALLY: OSCR 2 — CAI 9
■ METRIC PARITY
options-implied-move
—
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OSCR VS. CAI) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC OSCR CAI SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% 4.40% -39.40 CAI /roic <GO>
EV/EBITDA & P/E Valuation — 95.0x — TIE /valuation <GO>
Free Cash Flow Yield 11.51% 0.65% +10.86 OSCR /fcf-yield <GO>
Operating Margin -60.00% 5.60% -65.60 CAI /operating-margins <GO>
Net Profit Margin -60.00% -8.40% -51.60 CAI /net-margins <GO>
Revenue Growth (YoY) 39.00% 97.00% -58.00 CAI /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.45 9.79 -9.34 CAI /balance-sheet <GO>
Piotroski F-Score Quality 6/9 8/9 -2.00 CAI /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 44.2 67.6 -23.40 CAI /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 0.97 0.91 +0.06 OSCR /macro-sensitivity <GO>
Forward P/E Multiple 23.0x 21.0x +2.00 CAI /forward-pe <GO>
Enterprise Scale & Market Cap $9.50B $10.21B -$709.8M CAI /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR OSCR REV CAI REV OSCR GROSS % CAI GROSS % OSCR FCF CAI FCF
FY 2025 $28.6M $812.0M — — $1.09B $66.9M
FY 2024 $20.6M $412.3M — — $977.3M -$253.6M
FY 2023 $21.4M $306.1M — — -$273.1M -$289.9M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OSCR // BETA 0.97
CAI // BETA 0.91